MARY REYNOLDS: Open Payments
NPI 1194962241 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,830 in 95 payments from 23 companies in 2025. Trend: 2023 $2,105 · 2024 $2,005 · 2025 $1,830
Food & beverage: $1,830
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $274 |
| Novo Nordisk Inc | 19 | $267 |
| Exact Sciences Corporation | 6 | $159 |
| AstraZeneca Pharmaceuticals LP | 4 | $154 |
| Lilly USA, LLC | 7 | $151 |
| ABBVIE INC. | 8 | $148 |
| PFIZER INC. | 5 | $100 |
| Amgen Inc. | 3 | $68 |
| PROTEGA PHARMACEUTIALS INC | 1 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
Products named: TRELEGY ELLIPTA, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, AIRSUPRA, Wegovy, UBRELVY, QULIPTA.
Industry payments across FL — which companies pay providers there.
